REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

 

Current tag:

Stem Cell Insights Collection 2010

Issues and Evaluation from Pharma Leaders

How does the pharma industry view application of stem cell technologies? Where are R&D efforts needed, and where does academic research not fulfill expectations? What is the role of suppliers in the field?

Read fresh answers from the leaders, provided exclusively to readers of B2Bioworld. Published only here, and all in one.

 

(C) Boehringer Ingelheim(C) Wolf G Kroner 2009(C) Wolf G Kroner 2009(C) Hoffmann-La Roche 2009

 

We are obliged to more and more move away from animal models
- Prof. Andreas Barner, Boehringer Ingelheim


Preparing for Another Level of Innovation
- Dr Mark Fishman, Novartis


Clear away complete confusion of terms
- Dr Bernhard Kirschbaum, Merck Serono


Stem Cells: a discovery tool and a potential therapeutic modality
- Dr Jonathan Knowles, Hoffmann-La Roche

 

(C) R.McKernan 2009(C) Wolf G Kroner 2009(C) M. Krogsgaard(C) K. Stoeckli

 

It really started last year…
- Dr Ruth McKernan, Pfizer Regenerative Medicine


Stem Cells and Vaccines Production
- Dr Majid Mehtali, Vivalis


Doing our business a little bit differently than the others in the industry
- Dr Mads Krogsgaard, Novo Nordisk


Triggering Regenerative Functions with Transplanted Cells and Small Molecules
- Dr Kurt Stoeckli, Biological Sciences/Discovery Sanofi-Aventis

 

(C) P. Vallance(C) Hugh Ilyine 2009(C) S. Tegethoff 2009(C) D. Hay 2009


Stem Cell Research in GlaxoSmithKline and Beyond
- Dr Patrick Vallance, GlaxoSmithKline Drug Discovery


Stem Cells – Failings and Deliveries
- Hugh Ilyine, Consultant & Guest Editor


Patenting Stem Cells
- Dr. Sebastian Tegethoff, 24IP


Drug Testing with Embryonic Stem Cells – Towards Standards For Assays
– Dr David C Hay, University of Edinburgh, MRC Centre for Regenerative Medicine


L’Oréal avance dans les cellules souches
- Report by Hélène Guyot (with summary in English)


Buy the Entire Collection of Articles on Stem Cells here

 

Related Article 

Bayer AG: New Stakes in Stem Cells
- Prof. Andreas Busch, Bayer AG



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

13 articles, advert-free

Pfizer Regenerative Medicine: “It really started last year…”

Ruth McKernan (c) Pfizer Inc.Pfizer is rapidly expanding work on stem cell applications. A first hand account by Dr Ruth McKernan, the global CSO of Pfizer’s activities in the field, an evaluation of toxicity screening with embryonic stem cells and needs to move forward.

 

 

 

 

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

exclusive interview, 3 pages

Top 10 Tags

All Tags (2094)